Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Rescigno

Showing results (91-100 of 216) with videos related to

Pageof 22
Sort By:
The Journal of Clinical Investigation|May 6, 2021
One dose of SARS-CoV-2 vaccine exponentially increases antibodies in individuals who have recovered from symptomatic COVID-19Riccardo Levi, Elena Azzolini, Chiara Pozzi, et al.
Trends in Immunology|January 28, 2023
COVID-19 vaccines and a perspective on AfricaAlberto Mantovani, Maria Rescigno, Guido Forni, et al.
JAMA|July 7, 2022
Association Between BNT162b2 Vaccination and Long COVID After Infections Not Requiring Hospitalization in Health Care WorkersElena Azzolini, Riccardo Levi, Riccardo Sarti, et al.
Gut|February 4, 2012
Probiotic and postbiotic activity in health and disease: comparison on a novel polarised ex-vivo organ culture modelKaterina Tsilingiri, Theolis Barbosa, Giuseppe Penna, et al.
The British Journal of Nutrition|April 8, 2010
Gut health: predictive biomarkers for preventive medicine and development of functional foodsRaish Oozeer, Maria Rescigno, R Paul Ross, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 19, 2010
Different bacterial pathogens, different strategies, yet the aim is the same: evasion of intestinal dendritic cell recognitionSammy Bedoui, Andreas Kupz, Odilia L Wijburg, et al.
European Journal of Cancer (Oxford, England : 1990)|November 13, 2020
Evidence for interleukin 17 involvement in severe immune-related neuroendocrine toxicityLuca Mazzarella, Silvia Giugliano, Paolo D'Amico, et al.
European Journal of Immunology|October 2, 2002
Toll-like receptor 4 is not required for the full maturation of dendritic cells or for the degradation of Gram-negative bacteriaMaria Rescigno, Matteo Urbano, Monica Rimoldi, et al.
Frontiers in Microbiology|August 11, 2025
A multi-strain probiotic formulation preserves intestinal epithelial and vascular barriers during enteropathogenic infectionAnna Maria Naso, Michela Lizier, Carmen Correale, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 22, 2023
Association Between Duration of SARS-CoV-2 Positivity and Long COVIDChiara Pozzi, Riccardo Sarti, Riccardo Levi, et al.
Pageof 22

Showing results (91-100 of 216) with videos related to

Sort By:
Pageof 22
The Journal of Clinical Investigation|May 6, 2021
One dose of SARS-CoV-2 vaccine exponentially increases antibodies in individuals who have recovered from symptomatic COVID-19Riccardo Levi, Elena Azzolini, Chiara Pozzi, et al.
Trends in Immunology|January 28, 2023
COVID-19 vaccines and a perspective on AfricaAlberto Mantovani, Maria Rescigno, Guido Forni, et al.
JAMA|July 7, 2022
Association Between BNT162b2 Vaccination and Long COVID After Infections Not Requiring Hospitalization in Health Care WorkersElena Azzolini, Riccardo Levi, Riccardo Sarti, et al.
Gut|February 4, 2012
Probiotic and postbiotic activity in health and disease: comparison on a novel polarised ex-vivo organ culture modelKaterina Tsilingiri, Theolis Barbosa, Giuseppe Penna, et al.
The British Journal of Nutrition|April 8, 2010
Gut health: predictive biomarkers for preventive medicine and development of functional foodsRaish Oozeer, Maria Rescigno, R Paul Ross, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 19, 2010
Different bacterial pathogens, different strategies, yet the aim is the same: evasion of intestinal dendritic cell recognitionSammy Bedoui, Andreas Kupz, Odilia L Wijburg, et al.
European Journal of Cancer (Oxford, England : 1990)|November 13, 2020
Evidence for interleukin 17 involvement in severe immune-related neuroendocrine toxicityLuca Mazzarella, Silvia Giugliano, Paolo D'Amico, et al.
European Journal of Immunology|October 2, 2002
Toll-like receptor 4 is not required for the full maturation of dendritic cells or for the degradation of Gram-negative bacteriaMaria Rescigno, Matteo Urbano, Monica Rimoldi, et al.
Frontiers in Microbiology|August 11, 2025
A multi-strain probiotic formulation preserves intestinal epithelial and vascular barriers during enteropathogenic infectionAnna Maria Naso, Michela Lizier, Carmen Correale, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 22, 2023
Association Between Duration of SARS-CoV-2 Positivity and Long COVIDChiara Pozzi, Riccardo Sarti, Riccardo Levi, et al.
Pageof 22